首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D.
【24h】

c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D.

机译:c-Jun N末端激酶2(JNK2)拮抗JNK1在抗维生素D的人骨髓白血病细胞中分化的信号。

获取原文
获取原文并翻译 | 示例
           

摘要

1,25-Dihydroxyvitamin D3 (1,25D) induces differentiation of myeloid leukemia cells, but resistant cells are also encountered. We studied the mechanistic basis for the resistance in a model system using enhancers of 1,25D, the antioxidant carnosic acid and a kinase inhibitor SB202190. Knock-down (KD) of JNK2p54 unexpectedly increased the intensity of differentiation induced by the 1,25D, carnosic acid and SB202190 (DCS) combination. This was associated with upregulation of activated JNK1p46, and the transcription factors regulated by the JNK pathway, c-Jun, ATF2 and JunB, as well as C/EBP beta. In contrast, KD of JNK1p46 reduced the intensity of DCS-induced differentiation, and partially abrogated activation of c-Jun/AP-1 transcription factors.
机译:1,25-二羟基维生素D3(1,25D)诱导骨髓白血病细胞分化,但也遇到了抗性细胞。我们在使用1,25D增强剂,抗氧化剂肌酸和激酶抑制剂SB202190的模型系统中研究了抗药性的机理基础。 JNK2p54的敲低(KD)意外地增加了1,25D,肌酸和SB202190(DCS)组合诱导的分化强度。这与激活的JNK1p46的上调以及受JNK途径,c-Jun,ATF2和JunB以及C / EBP beta调控的转录因子有关。相反,JNK1p46的KD降低了DCS诱导的分化强度,并部分废除了c-Jun / AP-1转录因子的激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号